1. Home
  2. ITOS vs BYND Comparison

ITOS vs BYND Comparison

Compare ITOS & BYND Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ITOS
  • BYND
  • Stock Information
  • Founded
  • ITOS 2011
  • BYND 2009
  • Country
  • ITOS United States
  • BYND United States
  • Employees
  • ITOS N/A
  • BYND N/A
  • Industry
  • ITOS Biotechnology: Biological Products (No Diagnostic Substances)
  • BYND Packaged Foods
  • Sector
  • ITOS Health Care
  • BYND Consumer Staples
  • Exchange
  • ITOS Nasdaq
  • BYND Nasdaq
  • Market Cap
  • ITOS 270.7M
  • BYND 207.0M
  • IPO Year
  • ITOS 2020
  • BYND 2019
  • Fundamental
  • Price
  • ITOS $7.35
  • BYND $2.53
  • Analyst Decision
  • ITOS Strong Buy
  • BYND Sell
  • Analyst Count
  • ITOS 3
  • BYND 5
  • Target Price
  • ITOS $26.00
  • BYND $4.70
  • AVG Volume (30 Days)
  • ITOS 489.4K
  • BYND 2.1M
  • Earning Date
  • ITOS 05-09-2025
  • BYND 05-07-2025
  • Dividend Yield
  • ITOS N/A
  • BYND N/A
  • EPS Growth
  • ITOS N/A
  • BYND N/A
  • EPS
  • ITOS N/A
  • BYND N/A
  • Revenue
  • ITOS $35,000,000.00
  • BYND $326,452,000.00
  • Revenue This Year
  • ITOS N/A
  • BYND $2.64
  • Revenue Next Year
  • ITOS $31.74
  • BYND $3.35
  • P/E Ratio
  • ITOS N/A
  • BYND N/A
  • Revenue Growth
  • ITOS 177.89
  • BYND N/A
  • 52 Week Low
  • ITOS $4.80
  • BYND $2.50
  • 52 Week High
  • ITOS $18.75
  • BYND $10.31
  • Technical
  • Relative Strength Index (RSI)
  • ITOS 62.54
  • BYND 33.95
  • Support Level
  • ITOS $7.01
  • BYND $2.50
  • Resistance Level
  • ITOS $7.56
  • BYND $2.85
  • Average True Range (ATR)
  • ITOS 0.49
  • BYND 0.19
  • MACD
  • ITOS 0.26
  • BYND 0.00
  • Stochastic Oscillator
  • ITOS 92.39
  • BYND 2.04

About ITOS iTeos Therapeutics Inc.

ITeos Therapeutics Inc is a biopharmaceutical company. It designs novel product candidates with optimized pharmacologic properties to improve clinical outcomes by restoring the immune response against cancer. The company's product candidates include EOS-850 which is an Adenosine A2A receptor-specific antagonist, EOS-448 which is an ADCC-enabled, anti-TIGIT immune checkpoint blocking antibody among other drug candidates.

About BYND Beyond Meat Inc.

Beyond Meat Inc is a provider of plant-based meat company offering a portfolio of revolutionary plant-based meats. It builds meat directly from plants, an innovation that enables consumers to experience the taste, texture and other sensory attributes of popular animal-based meat products while enjoying the nutritional and environmental benefits of eating plant-based meat product It has products such as burgers, sausage, ground beef, jerky, meatballs and chicken. The company generates revenue from sales of its products to the customers across mainstream grocery, mass merchandiser, club store, convenience store and natural retailer channels and various food-away-from-home channels, including restaurants, foodservice outlets and schools, mainly in the United States.

Share on Social Networks: